[{"title": "<p>En cas de remplacement valvulaire total, parmi les arguments suivants, lesquels sont en faveur d'une bioproth&egrave;se plut&ocirc;t que d'une proth&egrave;se m&eacute;canique ?</p>", "feedback": "<p>Anticoagulation pr&eacute;existante pour une ACFA : les valves m&eacute;caniques n&eacute;cessitant une anticoagulation curative, la pr&eacute;sence d'une anticoagulation au pr&eacute;alable est donc logiquement plus en faveur d'une proth&egrave;se m&eacute;canique.</p>\n<p>Grossesse : chez la jeune femme en &acirc;ge de procr&eacute;er, on pr&eacute;f&egrave;rera une bioproth&egrave;se afin d&rsquo;&eacute;viter les risques t&eacute;ratog&egrave;nes du traitement anticoagulant qui, de plus, est difficile &agrave; &eacute;quilibrer au cours de la grossesse en raison de la variation de la vol&eacute;mie.</p>\n<p>Age : les patients au-del&agrave; de 65-70 ans recevront une bioproth&egrave;se qui ne n&eacute;cessite pas de traitement anticoagulant mais avec un risque de d&eacute;g&eacute;n&eacute;rescence structurelle apr&egrave;s 10 &agrave; 15 ans de fonctionnement avec une bioproth&egrave;se mitrale alors que cette d&eacute;g&eacute;n&eacute;rescence ne surviendra qu&rsquo;apr&egrave;s une vingtaine d&rsquo;ann&eacute;es avec une bioproth&egrave;se aortique. A l&rsquo;inverse, les patients de moins de 65-70 ans recevront plus volontiers des proth&egrave;ses m&eacute;caniques mais seront soumis &agrave; vie &agrave; un traitement anticoagulant.</p>\n<p>Activit&eacute; sportive et mode de vie : le choix du patient est important &agrave; prendre en compte ! Un patient pratiquant des activit&eacute;s &agrave; risques (escalade, moto...) peut souhaiter une bioproth&egrave;se afin de pourvoir continuer son activit&eacute; sans &ecirc;tre embeter par des anticoagulants...</p>", "type": "qcm", "choices": ["Anticoagulation pr\u00e9existante pour une ACFA", "Femme ayant un projet de grossesse", "Patient \u00e2g\u00e9 de 75 ans", "Patient pratiquant de l'escalade r\u00e9guli\u00e8rement", "Hyperparathyroidie"], "answers": [false, true, true, true, false]}, {"title": "<p>Un patient vient voir son cardiologue pour une consultation dans le cadre de son suivi de sa proth&egrave;se aortique. Il est trait&eacute; par AVK au long cours.</p>\n<p>Quelle(s) est (sont) la (les) complication(s) grave(s) de ce patient porteur de proth&egrave;se valvulaire cardiaque?</p>", "feedback": "<p>Les complications graves sont l'endocardite infectieuse, les embolies syst&eacute;miques, l'h&eacute;morragie sous AVK et les thromboses de proth&egrave;se.</p>", "type": "qcm", "choices": ["h\u00e9morragie sous AVK", "thromboses de proth\u00e8se", "dissection carotidienne", "embolies syst\u00e9miques", "endocardite infectieuse"], "answers": [true, true, false, true, false]}, {"title": "<p>Quelle est la proposition inexacte concernant les complications des proth&egrave;ses&nbsp;valvulaires ?</p>", "feedback": "<p>L'endocardite de Libman-Sachs est une atteinte cardiaque du lupus associ&eacute; &agrave; un SAPL. A l'ETT on observe une image d'addition souvent &agrave; la pointe d'un feuillet avec un aspect dit en \"gant de boxe\".</p>", "type": "qru", "choices": ["Thrombose de proth\u00e8se", "Endocardite infectieuse", "Endocardite de Libman-Sacks", "H\u00e9morragies (li\u00e9es aux AVK)", "Complications emboliques : AVC, isch\u00e9mie aigu\u00eb de membres\u2026", "D\u00e9sinsertion de proth\u00e8se", "D\u00e9g\u00e9n\u00e9rescence", "Fuite intra-proth\u00e9tique", "Fuite p\u00e9ri-proth\u00e9tique", "H\u00e9molyse chronique", "H\u00e9molyse aigu\u00eb"], "answer": 2}, {"title": "<p>Quels sont les arguments principaux en faveur d&rsquo;une valve m&eacute;canique&nbsp;?</p>", "feedback": "<p>L'&acirc;ge est l'&eacute;l&eacute;ment le plus important, mais il n'est pas seul, il existe d'autres crit&egrave;res : choix du patient, d&eacute;sir de grossesse pour les femmes en &acirc;ge de procr&eacute;er, traitement anticoagulant pr&eacute;alable, suivi du patient.</p>", "type": "qcm", "choices": ["\u00c2ge < 60-65 ans", "\u00c2ge > 60-65 ans", "L'\u00e2ge ne rentre pas en compte dans la d\u00e9cision", "Pr\u00e9f\u00e9rences du patient", "Pas de contre indications aux AVK", "Pas de d\u00e9sir de grossesse (pour les femmes en \u00e2ge de procr\u00e9er)", "Absence de pacemaker", "Suivi possible"], "answers": [true, false, false, true, true, true, false, true]}, {"title": "<p>Chez l'enfant, l'antibioprophylaxie dans l'endocardite infectieuse est recommand&eacute;e en cas de :</p>", "feedback": "<p>Annale ECN 2019</p>\n<p>&nbsp;</p>\n<p>Groupe A (haut risque) : proth&egrave;se (m&eacute;canique ou biologique), cardiopathie cong&eacute;nitale cyanog&egrave;ne non op&eacute;r&eacute;es et d&eacute;rivations chirurgicales, ant&eacute;c&eacute;dent EI</p>\n<p>&nbsp;</p>\n<p>Groupe B (risque moins &eacute;lev&eacute;) : valvulopathies (IA, IM, RA), prolapsus de la valve mitrale avec IM et/ou &eacute;paississement valvulaire, bicuspidie, cardiopathie cong&eacute;nitales non cyanog&egrave;nes (sauf communication interauriculaire)</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Seules les cardiopathies &agrave; <strong><u>haut risque</u></strong> sont concern&eacute;es par l'antibioprophylaxie. La CIA n'est pas &agrave; risque d'EI</p>", "type": "qcm", "choices": ["proth\u00e8se valvulaire", "communication inter atriale", "cardiopathie cyanog\u00e8ne non op\u00e9r\u00e9e", "coarctation de l'aorte", "ant\u00e9c\u00e9dent d'endocardite infectieuse"], "answers": [true, false, true, false, true]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de d&eacute;g&eacute;n&eacute;rescence des bioproth&egrave;ses ?</p>\n<p>&nbsp;</p>", "feedback": "<p>= in&eacute;vitable : favoris&eacute; par l&rsquo;&acirc;ge jeune, la position mitrale, la grossesse,ou des anomalies du</p>\n<p>bilan phosphocalcique (hyperparathyro&iuml;die, insuffisance r&eacute;nale chronique).</p>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["Insuffisance h\u00e9patique", "Hypoparathyro\u00efdie", "Sujet \u00e2g\u00e9", "Position mitrale", "Grossese"], "answers": [false, false, false, false, false]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de d&eacute;g&eacute;n&eacute;rescence des bioproth&egrave;ses ?</p>\n<p>&nbsp;</p>", "feedback": "<p>Les facteurs de risques (fiche Lisa) sont le sexe masculin, l&rsquo;implantation &agrave; un &acirc;ge jeune, l&rsquo;insuffisance r&eacute;nale, les anomalies du m&eacute;tabolisme calcique, la dyslipid&eacute;mie, mismatch patient/proth&egrave;se et les bioproth&egrave;ses en position mitrale.</p>\n<p>NB : Le coll&egrave;ge de cardiologie pr&eacute;cise aussi l'IRC (qui semble plausible vis &agrave; vis du trouble du m&eacute;tabolisme calcique) ainsi que l'hyperthyro&iuml;die qui peut &ecirc;tre une coquille (&agrave; la place de l'hyperparathyroidie) car je n'ai pas r&eacute;ussi &agrave; retrouver cette information ailleurs.&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["Position mitrale", "Position pulmonaire", "Hyperparathyro\u00efdie", "Insuffisance surr\u00e9nalienne", "Insuffisance cardiaque"], "answers": [true, false, true, false, false]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de d&eacute;g&eacute;n&eacute;rescence des bioproth&egrave;ses ?</p>\n<p>&nbsp;</p>", "feedback": "<p>&nbsp;</p>\n<p>= in&eacute;vitable : favoris&eacute; par l&rsquo;&acirc;ge jeune, la position mitrale, la grossesse,ou des anomalies du</p>\n<p>bilan phosphocalcique (hyperparathyro&iuml;die, insuffisance r&eacute;nale chronique).</p>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["Insuffisance r\u00e9nale chronique", "Age jeune", "Allaitement", "Hypermagn\u00e9s\u00e9mie", "Position mitrale"], "answers": [true, true, false, false, true]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de risque &agrave; rechercher n&eacute;cessistant une majoration de l'INR ciblee sur une valve m&eacute;canique ?</p>\n<p>&nbsp;</p>", "feedback": "<p>- Position : mitrale, tricuspide et &eacute;galement pulmonaire selon la fiche Lisa&nbsp;</p>\n<p>- Ant&eacute;c&eacute;dent thromboembolique art&eacute;riel (AVC/AIT&hellip;)</p>\n<p>- Diam&egrave;tre de l&rsquo;OG &gt; 50 mm</p>\n<p>- Hypercoagulabilit&eacute;</p>\n<p>- FA</p>\n<p>- RM associ&eacute;</p>\n<p>- FEVG &lt; 35%&nbsp;</p>\n<p>-&nbsp; Contraste spontan&eacute; dense dans l&rsquo;OG (sludge)</p>", "type": "qcm", "choices": ["Position mitrale", "Position tricupside", "Insuffisance tricupside", "Position aortique", "R\u00e9tr\u00e9cissement aortique associ\u00e9"], "answers": [true, true, false, false, false]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de risque &agrave; rechercher pour ajuster correctement l'INR sur une valve m&eacute;canique ?</p>\n<p>&nbsp;</p>", "feedback": "<p><em><strong>Facteurs de risques li&eacute;s au patient&nbsp;:</strong></em></p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Toute proth&egrave;se m&eacute;canique en position mitrale, tricuspide ou pulmonaire (toujours cit&eacute;e dans la fiche lisa)</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Ant&eacute;c&eacute;dent de maladie thrombo-embolique</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Fibrillation atriale</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; <strong>OG</strong> dilat&eacute;e avec un diam&egrave;tre &gt; 50mm</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Contraste spontan&eacute; dense dans l&rsquo;OG (sludge)</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; R&eacute;tr&eacute;cissement mitral associ&eacute;</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Alt&eacute;ration de la FEVG &lt; 35%</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; &Eacute;tat d&rsquo;hypercoagulabilit&eacute; (SAPL)</p>\n<p>&nbsp;</p>\n<p>Source : fiche Lisa&nbsp;</p>", "type": "qcm", "choices": ["Insuffisance aortique", "Fibrillation atriale", "FEVG<35%", "Ant\u00e9c\u00e9dent thromboembolique", "Diam\u00e8tre de l'oreillette droite >50mm"], "answers": [false, true, true, true, false]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des facteurs de risque &agrave; rechercher pour ajuster correctement l'INR sur une valve m&eacute;canique ?</p>\n<p>&nbsp;</p>", "feedback": "<p>- Position : mitrale, tricuspide, pulmonaire</p>\n<p>- Ant&eacute;c&eacute;dent thromboembolique art&eacute;riel (AVC/AIT&hellip;)</p>\n<p>- Diam&egrave;tre de l&rsquo;OG &gt; 50 mm</p>\n<p>- Hypercoagulabilit&eacute; (selon les recommandations am&eacute;ricaines)</p>\n<p>- FA</p>\n<p>- RM associ&eacute;</p>\n<p>- FEVG &lt; 35%&nbsp;</p>", "type": "qcm", "choices": ["Fibrillation atriale", "R\u00e9tr\u00e9cissement mitral", "Tachycardie ventriculaire", "BAV 3", "Ant\u00e9c\u00e9dent d'AVC"], "answers": [false, true, false, false, true]}, {"title": "<p>Cochez la r&eacute;pnse exacte &agrave; propos du d&eacute;lai quand doit &ecirc;tre r&eacute;aliser le bilan post-op&eacute;ratoire apr&egrave;s changement valvulaire avec le cardiologue?</p>\n<p>&nbsp;</p>", "feedback": "<p class=\"u-ckm-anchor__container--content\" style=\"text-align: justify;\">Le suivi est r&eacute;alis&eacute; &agrave; 1 mois, puis tous les 3 mois par le m&eacute;decin traitant, afin de v&eacute;rifier notamment l'&eacute;tat clinique et l'&eacute;quilibre du traitement anticoagulant par les AVK.</p>\n<p class=\"u-ckm-anchor__container--content\" style=\"text-align: justify;\">La consultation du cardiologue a lieu au 2&ndash;3 <sup>e </sup>mois postop&eacute;ratoire, &agrave; la fin de la convalescence, notamment pour la r&eacute;alisation de l'ETT de r&eacute;f&eacute;rence. Le patient est ensuite suivi par le cardiologue 1 &agrave; 2 fois/an.</p>\n<div class=\"inline-image figure u-ckm-anchor__container--content\"><span id=\"hl0000202\" class=\"u-ckm-anchor__anchor--content\"></span><span id=\"f0070\" class=\"u-ckm-anchor__anchor--content\"></span>\n<figure id=\"img-container-hl0000202\">\n<div class=\"sized-image-container--outer\">&nbsp;</div>\n</figure>\n</div>", "type": "qru", "choices": ["3 semaines", "12 semaines", "16 semaines", "20 semaines", "24 semaines"], "answer": 1}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos du d&eacute;lai d'anticoagulation apr&egrave;s pose d'une bioproth&egrave;se ?</p>\n<p>&nbsp;</p>", "feedback": "<p>Apr&egrave;s pose de bioproth&egrave;se : anticoagulation curative pendant 3 mois si rythme sinusal (temps pour endoth&eacute;lialisation de la valve)</p>", "type": "qcm", "choices": ["4 semaines", "8 semaines", "12 semaines", "16 semaines", "20 semaines"], "answers": [false, false, true, false, false]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos des endocardite infectieuse post op&eacute;ration valvulaire survenant &lt;1an apr&egrave;s op&eacute;ration ?</p>\n<p>&nbsp;</p>", "feedback": "<p>= &lt; 1 an postop&eacute;ratoire : contamination perop&eacute;ratoire par des germes hospitaliers multir&eacute;sistants (S. aureus, staphylocoque coagulase n&eacute;gative&hellip;)</p>\n<p>- EI g&eacute;n&eacute;ralement aigu&euml;, avec d&eacute;sinsertion de proth&egrave;se</p>\n<p>- R&eacute;intervention pr&eacute;coce g&eacute;n&eacute;ralement n&eacute;cessaire : 50% de mortalit&eacute;&nbsp;</p>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["Contamination par des germes multir\u00e9sistants", "On retrouvent souvent une d\u00e9sinsertion de proth\u00e8se", "Une r\u00e9intervention pr\u00e9coce est g\u00e9n\u00e9ralement n\u00e9cessaire", "Le pronostic est excellent", "On retrouve souvent du staphylocoque dor\u00e9"], "answers": [true, true, true, false, true]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos du pourcentage de mortalit&eacute; des endocardites infectieuse post op&eacute;ration valvulaire survenant &lt;1an apr&egrave;s op&eacute;ration ?</p>\n<p>&nbsp;</p>", "feedback": "<p>= &lt; 1 an postop&eacute;ratoire : contamination perop&eacute;ratoire par des germes hospitaliers multir&eacute;sistants (S. aureus, staphylocoque coagulase n&eacute;gative&hellip;)</p>\n<p>- EI g&eacute;n&eacute;ralement aigu&euml;, avec d&eacute;sinsertion de proth&egrave;se</p>\n<p>- R&eacute;intervention pr&eacute;coce g&eacute;n&eacute;ralement n&eacute;cessaire : 50% de mortalit&eacute;&nbsp;</p>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["10", "20", "30", "40", "50"], "answers": [false, false, false, false, true]}, {"title": "<p>Cochez la(les) r&eacute;ponse(s) exacte(s) &agrave; propos du pourcentage de mortalit&eacute; lors d'une thrombose aigu&euml; valvulaire ?</p>\n<p>&nbsp;</p>", "feedback": "<p>Thrombose aigu&euml; : r&eacute;intervention en urgence pour changement de valve : 30% de mortalit&eacute;. Fibrinolyse indiqu&eacute;e si : patient instable &agrave; haut risque chirurgical, si chirurgie cardiaque ne pouvant &ecirc;tre r&eacute;alis&eacute;e dans l&rsquo;urgence, ou si thrombose de proth&egrave;se tricuspide ou pulmonaire</p>", "type": "qcm", "choices": ["55%", "50%", "40%", "30%", "20%"], "answers": [false, false, false, true, false]}, {"title": "<p>Quelle est la mesure indispensable de la prise en charge d'une thrombose aigue obstructive de valve m&eacute;canique cardiaque?</p>", "feedback": "<p>\"La prise en charge comporte :<br>&ndash; l'hospitalisation pour r&eacute;intervention d'urgence pour changement de valve en cas de thrombose aigu&euml; de proth&egrave;se (mortalit&eacute; de 30 %) ;<br>&ndash; en cas de contre-indication &agrave; la chirurgie ou dans les formes subaigu&euml;s r&eacute;sistantes au traitement anticoagulant, la thrombolyse, avec parfois de bons r&eacute;sultats ;<br>&ndash; en cas de dysfonction de proth&egrave;se de moindre gravit&eacute;, la r&eacute;&eacute;quilibration du traitement anticoagulant avec passage transitoire &agrave; l'h&eacute;parine si n&eacute;cessaire ou adjonction d'antiagr&eacute;gant plaquettaire.\"</p>\n<p>Le coll&egrave;ge parle &eacute;galement d'adapter l'anticoagulation, mais ici ce qu'il faut retenir c'est l'intervention en urgence&nbsp;</p>", "type": "qru", "choices": ["R\u00e9intervention en urgence pour changement de valve", "Fibrinolyse IV", "Mise sous HNF curatif", "Mise sous HBPM curatif", "Augmenter la posologie d'AVK"], "answer": 0}, {"title": "<p>Un patient &acirc;g&eacute; de 69 ans a &eacute;t&eacute; op&eacute;r&eacute; d'une bicuspidie aortique avec fuite valvulaire. Une bioproth&egrave;se a &eacute;t&eacute; mise en place.</p>\n<p>Concernant les bioproth&egrave;ses valvulaires aortiques, quelle(s) est (sont) la (les) proposition(s) exacte(s) ?</p>", "feedback": "<p>Les valves biologiques sont le plus souvent des x&eacute;nogreffes, valves d'origine animale constitu&eacute;es de p&eacute;ricarde principalement bovin, ou de valves aortiques d'origine porcine.&nbsp;</p>\n<p>Leur durabilit&eacute; est limit&eacute;e &agrave; 10&ndash;15 ans en moyenne, avec des d&eacute;g&eacute;n&eacute;rescences parfois plus pr&eacute;coces surtout chez les sujets jeunes, ou en fonction du type de proth&egrave;se. &nbsp;Les bioproth&egrave;ses ne n&eacute;cessitent pas d'anticoagulants au-del&agrave; du 3e mois postop&eacute;ratoire si le rythme est sinusal</p>\n<p>Les bioproth&egrave;ses sont le plus souvent mont&eacute;es sur une armature de m&eacute;tal et donc relativement encombrantes.</p>\n<p>&nbsp;</p>\n<p>Quel que soit le type de proth&egrave;se, le risque infectieux est majeur chez ces patients.</p>", "type": "qcm", "choices": ["les bioproth\u00e8ses sont le plus souvent en titane ou en carbone", "les bioproth\u00e8ses n\u00e9cessitent un traitement anticoagulant d\u00e9finitif", "la durabilit\u00e9 des bioproth\u00e8ses est limit\u00e9e", "le port d\u2019une bioproth\u00e8se valvulaire pr\u00e9vient la survenue d\u2019endocardite", "les bioproth\u00e8ses sont le plus souvent mont\u00e9es sur une armature en m\u00e9tal"], "answers": [false, false, true, false, true]}, {"title": "<p>Parmi les propositions suivantes, laquelle(lesquelles) s'applique(ent) aux proth&egrave;ses valvulaires m&eacute;caniques?</p>", "feedback": "<p>(A) Une an&eacute;mie h&eacute;molytique peut survenir en cas de d&eacute;sinsertion de proth&egrave;se avec pr&eacute;sence de schizocytes.</p>\n<p>(C) La d&eacute;g&eacute;n&eacute;rescence de proth&egrave;se est une complication des bioproth&egrave;ses.</p>\n<p>(DE) Les proth&egrave;ses m&eacute;caniques n&eacute;cessitent une anticoagulation par AVK &agrave; vie.</p>", "type": "qcm", "choices": ["An\u00e9mie h\u00e9molytique", "Thrombose de proth\u00e8se", "D\u00e9g\u00e9n\u00e9rescence de proth\u00e8se", "Anticoagulation par AOD", "Anticoagulation par AVK"], "answers": [true, true, false, false, true]}, {"title": "<p>Concernant les proth&egrave;ses valvulaires m&eacute;caniques, quelle(s) proposition(s) est(sont exacte(s)?</p>", "feedback": "<p>(A) Elle sont viables &agrave; vie.</p>\n<p>(C) Ils sont totalement contre-indiqu&eacute;s</p>\n<p>(D) Elle r&eacute;duit mais ne supprime pas le risque</p>\n<p>(E) les proth&egrave;ses r&eacute;centes avec ou sans FDR thrombotique li&eacute;s aux patients ont une cible INR entre 2,5 et 3,5</p><img src=data:image/png;base64,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>", "type": "qcm", "choices": ["Elles n\u00e9cessitent un changement au bout de 10-15 ans", "Il existe un risque de thrombose de proth\u00e8se", "Les anticoagulants oraux directs sont utilisables de mani\u00e8re transitoire", "L\u2019anticoagulation par AVK supprime le risque thrombotique", "Avec les proth\u00e8ses r\u00e9centes, l\u2019INR cible sera g\u00e9n\u00e9ralement entre 2,5 et 3,5"], "answers": [false, true, false, false, true]}, {"title": "<p>Concernant les bioprotheses valvulaires, quelle(s) proposition(s) est(sont) exacte(s)?</p>", "feedback": "<p>(A) Elles sont viables 10-15 ans en moyenne</p>\n<p>(C) Seulement 3 mois en post op&eacute;ratoire</p>\n<p>(D) Plus rapidement chez les jeunes</p>", "type": "qcm", "choices": ["Elles sont valable \u00e0 vie", "Elles sont souvent mont\u00e9es sur une armature en m\u00e9tal", "Elles n\u00e9cessitent une anticoagulation \u00e0 vie", "Elles d\u00e9g\u00e9n\u00e8rent plus rapidement chez les personnes \u00e2g\u00e9es", "Elles sont d\u2019origine animale"], "answers": [false, true, false, false, true]}, {"title": "<p>Concernant les bioproth&egrave;ses percutan&eacute;es aortiques, quelle(s) proposition(s) est(sont) exacte(s)?</p>", "feedback": "<p>(A) Comme pour toute bioproth&egrave;se, un risque de d&eacute;g&eacute;n&eacute;rescence existe et, &eacute;tant plus r&eacute;centes, leur durabilit&eacute; reste &agrave; d&eacute;finir.</p>\n<p>(BCDE) Elles ne n&eacute;cessitent pas d'anticoagulation au long cours, mais les patients sont trait&eacute;s par aspirine au long cours.</p>", "type": "qcm", "choices": ["Elles sont valables \u00e0 vie", "Elles n\u00e9cessitent une anticoagulation \u00e0 vie", "Elles n\u00e9cessitent une anticoagulation 3 mois en post op\u00e9ratoire \u00e0 pleine dose puis continu\u00e9 \u00e0 demi-dose", "Elles n\u00e9cessitent une double anti agr\u00e9gation plaquettaire \u00e0 vie", "Elles n\u00e9cessitent une anti-agr\u00e9gation par aspirine au long cours"], "answers": [false, false, false, false, true]}, {"title": "<p>Parmi les propositions suivantes, quelle(s) proposition(s) est(sont) exacte(s)?</p>", "feedback": "<p>Les proth&egrave;ses m&eacute;caniques sont g&eacute;n&eacute;ralement pr&eacute;f&eacute;r&eacute;es chez les sujets de moins de 60 ans pour les proth&egrave;ses aortiques ou de moins de 65 ans pour les proth&egrave;ses mitrales.</p>\n<p>Les proth&egrave;ses biologiques sont g&eacute;n&eacute;ralement indiqu&eacute;es chez les sujets de plus de 65 ans pour les proth&egrave;ses aortiques ou de plus de 70 ans pour les proth&egrave;ses mitrales (dont la durabilit&eacute; et moindre).</p>", "type": "qcm", "choices": ["En cas de remplacement valvulaire aortique, on pr\u00e9f\u00e9ra une valve m\u00e9canique avant 60 ans", "En cas de remplacement valvulaire aortique, on pr\u00e9f\u00e9ra une valve biologique avant 60 ans", "En cas de remplacement valvulaire mitrale, on pr\u00e9f\u00e9ra une valve m\u00e9canique avant 65 ans", "En cas de remplacement valvulaire mitrale, on pr\u00e9f\u00e9ra une valve biologique avant 65 ans", "Aucune r\u00e9ponse n\u2019est exacte"], "answers": [true, false, true, false, false]}, {"title": "<p>Parmi les propositions suivantes, quelle complication des proth&egrave;ses valvulaires est la plus fr&eacute;quente ?</p>", "feedback": "<p>Les complications par embolies syst&eacute;miques ou thrombose de proth&egrave;ses sont effectivement les plus fr&eacute;quentes.</p>", "type": "qru", "choices": ["Complication thromboembolique", "D\u00e9sinsertions de proth\u00e8se", "Endocardite infectieuse", "Mediastinite postop\u00e9ratoire", "An\u00e9mie h\u00e9molytique"], "answer": 0}, {"title": "<p>Parmi les propositions suivantes, quelle(s) situation(s) expose(ent) &agrave; une majoration du risque thrombo-embolique par rapport &agrave; un sujet indemne ?</p>", "feedback": "<p>Toutes ces situations augmentent le risque thrombo-embolique par rapport &agrave; un sujet indemne.&nbsp;</p>", "type": "qcm", "choices": ["Lors des premiers mois post-op\u00e9ratoires", "En cas de proth\u00e8se aortique", "En cas de proth\u00e8se d\u2019ancienne g\u00e9n\u00e9ration", "En cas d\u2019insuffisance cardiaque", "En cas de bioproth\u00e8se"], "answers": [true, true, true, true, true]}, {"title": "<p>A propos des thromboses de proth&egrave;ses valvulaires m&eacute;caniques, quelle(s) proposison(s) est(sont) exacte(s)?</p>", "feedback": "<p>(A) Le FDR principal est une anticoagulation insuffisante</p>\n<p>(BC) Roulement diastolique en cas de proth&egrave;se mitrale et souffle systolique en cas de proth&egrave;se aortique</p>\n<p>(E) Un febricule est fr&eacute;quent lors des&nbsp;thromboses de proth&egrave;ses&nbsp;</p>", "type": "qcm", "choices": ["Le facteur de risque principal est l\u2019apparition d\u2019un trouble du rythme associ\u00e9", "On entend un roulement diastolique en cas de proth\u00e8se aortique", "On entend un souffle systolique en cas de proth\u00e8se mitrale", "En cas de thrombose aigu\u00eb , une intervention chirurgicale est justifi\u00e9e", "Le diagnostic diff\u00e9rentiel principal est l\u2019endocardite infectieuse"], "answers": [false, false, false, true, true]}, {"title": "<p>A propos des d&eacute;sinsertions de proth&egrave;ses valvulaires, quelle(s) proposison(s) est(sont) exacte(s)?</p>", "feedback": "<p>(C) Uniquement en cas de d&eacute;sinsertion importante</p>\n<p>(D) Et systolique en cas de proth&egrave;se mitrale (m&eacute;canisme identique &agrave; l'insuffisance aortique / mitrale). C'est l'inverse pour les thromboses sur proth&egrave;se (m&eacute;canisme identique au r&eacute;trecissement)</p>\n<p>(E) An&eacute;mie h&eacute;molytique m&eacute;canique.&nbsp;</p>\n<p>NB : l'an&eacute;mie h&eacute;molytique n'est plus que cit&eacute;e pour les d&eacute;sinsertions de proth&egrave;ses et non pas les thromboses dans les r&eacute;f&eacute;rentiels en 2023</p>\n<p>Source : coll&egrave;ge cardiologie r2C p238</p>", "type": "qcm", "choices": ["Elles peuvent \u00eatre dues \u00e0 un l\u00e2chage de suture", "Elles peuvent \u00eatre dues \u00e0 une endocardite infectieuse", "Elles n\u00e9cessitent toujours une intervention chirurgicale", "On entend un souffle diastolique en cas de proth\u00e8se aortique", "Une an\u00e9mie normocytaire r\u00e9g\u00e9n\u00e9rative est \u00e9vocatrice"], "answers": [true, true, false, true, true]}, {"title": "<p>A propos des endocardites sur proth&egrave;se valvulaire, quelle(s) proposison(s) est(sont) exacte(s)?</p>", "feedback": "<p>(A) Il permet son diagnostic et son bilan d&rsquo;extension en cas d&rsquo;imagerie difficile par &eacute;chographie. Il est cependant ininterpretable dans les 3 mois post op&eacute;ratoire.</p>\n<p>(B) Staphylocoque</p>\n<p>(D) 50% de mortalit&eacute;&nbsp;</p>\n<p>(E) Des h&eacute;mocultures sont &agrave; r&eacute;aliser avant tout</p>", "type": "qcm", "choices": ["Le TEP-TDM est un examen qui peut avoir une place dans la d\u00e9marche diagnostique", "Les endocardites post op\u00e9ratoire pr\u00e9coces sont principalement dues au streptocoque", "En cas d\u2019endocardite post op\u00e9ratoire pr\u00e9coce, une r\u00e9intervention est tr\u00e8s souvent n\u00e9cessaire", "Le pronostic des endocardites post op\u00e9ratoire pr\u00e9coces est bon", "En cas de fi\u00e8vre chez un porteur de valve, l\u2019antibioth\u00e9rapie est \u00e0 d\u00e9buter directement avant toute chose"], "answers": [true, false, true, false, false]}, {"title": "<p>Chez un patient porteur d&rsquo;une valve m&eacute;canique &agrave; risque thrombotique faible, quel(s) facteur(s)vous ferait cibler un objectif d&rsquo;INR plus haut?</p>", "feedback": "<p>Informations <strong>rang A</strong> dans la fiche Lisa surveillance de porteur de proth&egrave;ses&nbsp;</p>\n<p>Risque thrombotique de proth&egrave;se faible =</p>\n<ul>\n<li>INR 2.5 sans FR li&eacute;s au patient&nbsp;</li>\n<li>INR 3 si au moins un FR</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p><em>Facteurs&nbsp;<strong>de risques li&eacute;s au patient :</strong></em></p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Toute proth&egrave;se m&eacute;canique en position mitrale, tricuspide ou pulmonaire</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Ant&eacute;c&eacute;dent de maladie thrombo-embolique</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Fibrillation atriale</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; OG dilat&eacute;e avec un diam&egrave;tre &gt; 50mm</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Contraste spontan&eacute; dense dans l&rsquo;OG (sludge)</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; R&eacute;tr&eacute;cissement mitral associ&eacute;</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Alt&eacute;ration de la FEVG &lt; 35%</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; &Eacute;tat d&rsquo;hypercoagulabilit&eacute; (SAPL)</p>", "type": "qcm", "choices": ["Proth\u00e8se en position pulmonaire", "Ant\u00e9c\u00e9dent de maladie thromboembolique", "Fibrillation atriale", "Insuffisance mitrale associ\u00e9e", "FEVG < 35%"], "answers": [true, true, true, false, true]}, {"title": "<p>De fa&ccedil;on g&eacute;n&eacute;rale, quelle est la valeur de l'INR cible chez un patient porteur d'une valve m&eacute;canique mitrale &agrave; risque thrombotique &eacute;lev&eacute; et avec un SAPL ?</p>", "feedback": "<table class=\"wikitable\">\n<tbody>\n<tr>\n<td>Risque thrombotique de la proth&egrave;se</td>\n<td colspan=\"2\">Facteurs de risques li&eacute;s au patient</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Pas de facteur de risque</td>\n<td>&ge; 1 facteur de risque</td>\n</tr>\n<tr>\n<td>Faible\n<p><br>Moyen</p>\n<p><br>&Eacute;lev&eacute;</p>\n</td>\n<td>2,5\n<p><br>3,0</p>\n<p><br>3,5</p>\n</td>\n<td>3,0\n<p><br>3,5</p>\n<p><br>4,0</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><em><strong>Proth&egrave;se &agrave; faible risque</strong></em>&nbsp;: proth&egrave;se en position aortique de type Medtronic-Hall&reg; (Valve &agrave; disque), Saint-Jude&reg; et CarboMedics&reg; (Valves &agrave; double ailette).</p>\n<p><em><strong>Proth&egrave;se &agrave; risque interm&eacute;diaire</strong></em>&nbsp;: Proth&egrave;se en position aortique de type Bj&ouml;rk-Shiley&reg; (monodisque) et toutes les autres proth&egrave;ses &agrave; double ailette &agrave; risque non-faible.</p>\n<p><em><strong>Proth&egrave;se &agrave; risque &eacute;lev&eacute;</strong></em>&nbsp;: Valves d&rsquo;ancienne g&eacute;n&eacute;ration (non implant&eacute;es aujourd&rsquo;hui) type Starr&reg;.</p>\n<p><em><strong>Facteurs de risques li&eacute;s au patient&nbsp;:</strong></em></p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Toute proth&egrave;se m&eacute;canique en position mitrale, tricuspide ou pulmonaire</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Ant&eacute;c&eacute;dent de maladie thrombo-embolique</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Fibrillation atriale</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; OG dilat&eacute;e avec un diam&egrave;tre &gt; 50mm</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Contraste spontan&eacute; dense dans l&rsquo;OG (sludge)</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; R&eacute;tr&eacute;cissement mitral associ&eacute;</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; Alt&eacute;ration de la FEVG &lt; 35%</p>\n<p>- &nbsp; &nbsp; &nbsp; &nbsp; &Eacute;tat d&rsquo;hypercoagulabilit&eacute; (SAPL)</p>\n<p>Les proth&egrave;ses biologiques ne n&eacute;cessitent pas d&rsquo;anticoagulation, sauf en cas de facteurs de risques associ&eacute;s li&eacute;s au patient. Apr&egrave;s une bioproth&egrave;se aortique, une anti-agr&eacute;gation plaquettaire durant 3 mois est requise pour l&rsquo;endoth&eacute;lisation. Apr&egrave;s une bioproth&egrave;se mitrale ou tricuspide, une anticoagulation efficace durant 3 mois est requise pour l&rsquo;endoth&eacute;lisation</p>", "type": "qroc", "responses": ["4", "4,0"]}, {"title": "<p>Vous recevez un patient de 45 ans avec une valve m&eacute;canique aortique &agrave; risque thrombotique moyen sans ATCD de FA ni de thromboembolie. L'&eacute;chographie r&eacute;alis&eacute;e en post op&eacute;ratoire retrouve une FEVG &agrave; 40% et une absence de st&eacute;nose mitrale associ&eacute;e.</p>\n<p>Quel est l'INR cible ?</p>", "feedback": "<p>Cf tableau &agrave; la page 169 du coll&egrave;ge de cardio</p>\n<p>Si la proth&egrave;se est &agrave; risque thrombotique moyen, l'INR cible est de :</p>\n<p>- 3,5 si facteur de risque li&eacute; au patient (position mitrale ou tricuspide, ATCD de thromboembolie, FA, FEVG &lt; 35%, st&eacute;nose mitrale associ&eacute;e &lt; 2 cm&sup2;</p>\n<p>- 3,0 si pas de facteur de risque associ&eacute; <strong>ce qui est le cas ici</strong></p>", "type": "qroc", "responses": ["3", "3,0"]}, {"title": "<p>A propos des recommandations du mode de vie des patients porteurs d&rsquo;une bioproth&egrave;se aortique, quelle(s) propositoin(s) est(sont) exacte(s) ?</p>", "feedback": "<p>Les bioprtoh&egrave;ses ne n&eacute;cessitent pas de traitement anticoagulant, leurs porteurs n&rsquo;ont donc pas de carnet de surveillance &agrave; leur &eacute;gard.</p>", "type": "qcm", "choices": ["Le patient dispose d\u2019une carte de porteur de proth\u00e8se qu\u2019il doit garder sur lui", "Des consultations dentaires sont \u00e0 pr\u00e9voir de fa\u00e7on r\u00e9guli\u00e8res", "Un carnet de surveillance du traitement anticoagulant lui est fourni", "Une antibioprophylaxie devrait \u00eatre r\u00e9aliser avant tout geste d\u2019endoscopie digestive", "Une antibioprophylaxie devrait \u00eatre r\u00e9aliser avant tout geste dentaire n\u00e9cessitant une effraction de la gencive."], "answers": [true, true, false, false, true]}, {"title": "<p>Concernant les valves m&eacute;caniques :&nbsp;</p>", "feedback": "<p>A. faux chez les jeunes&nbsp;</p>\n<p>B. oui, ex FA&nbsp;</p>\n<p>C. faux, que bioproth&egrave;se (TAVI)</p>", "type": "qcm", "choices": ["Elles sont \u00e0 privil\u00e9gier chez les patients \u00e2g\u00e9s", "Elles sont \u00e0 privil\u00e9gier chez les patients anticoagul\u00e9s au long cours pour une autre raison", "Elles peuvent \u00eatre mises en place par voie percutan\u00e9e", "Elles exposent au risque h\u00e9morragique et thrombotique", "Elles subissent une d\u00e9g\u00e9n\u00e9rescence"], "answers": [false, true, false, true, false]}, {"title": "<p>Concernant les valves biologiques :</p>", "feedback": "<p>B. faux, apr&egrave;s 75 ans&nbsp;</p>\n<p>C. faux, plus &acirc;g&eacute;s&nbsp;</p>\n<p>D. faux, uniquement pour percutan&eacute;s et bioprpth&egrave;se chirurgicale apr&egrave;s 3 mois si ryhtme sinusal&nbsp;</p>", "type": "qcm", "choices": ["Elles sont \u00e0 favoriser en cas de risque h\u00e9morragique \u00e9lev\u00e9", "Apr\u00e8s 65 ans, le TAVI est \u00e0 envisager en premi\u00e8re intention", "Elles sont mises en place chez des patients g\u00e9n\u00e9ralement plus jeunes que les valves m\u00e9caniques", "Elle ne n\u00e9cessitent jamais d'anticoagulation efficace", "Il s'agit le plus souvent de x\u00e9nogreffe"], "answers": [true, false, false, false, true]}, {"title": "<p>Concernant les risque thrombotique des valves :&nbsp;</p>", "feedback": "<p>A. faux, AVK !!!!</p>\n<p>C. oui, AVC</p>\n<p>D. faux, diminue</p>", "type": "qcm", "choices": ["Le risque thrombotique des valves m\u00e9caniques diminue avec les AOD \u00e0 vie", "Le risque thrombotique est plus \u00e9lev\u00e9 en position mitrale", "Une embole syst\u00e9mique est le plus souvent c\u00e9r\u00e9brale", "En cas de thrombose obstructive de valve, le mouvement de l'\u00e9l\u00e9ment mobile de la proth\u00e8se augmente", "Un f\u00e9bricule peut \u00eatre pr\u00e9sent"], "answers": [false, true, true, false, true]}, {"title": "<p>Concernant la surveillance d'un porteur de valve cardiaque :&nbsp;</p>", "feedback": "<p>A. faux, si valve m&eacute;canique&nbsp;</p>\n<p>D. faux, ETT. ETO que si doute&nbsp;</p>", "type": "qcm", "choices": ["Les AVK sont maintenus \u00e0 vie si bioproth\u00e8se", "Le d\u00e9tartrage doit \u00eatre r\u00e9alis\u00e9 apr\u00e8s antibioprophylaxie", "Une proth\u00e8se mitrale peut favoriser une FA", "Une ETO r\u00e9guli\u00e8re est n\u00e9cessiaire au bon suivi", "Une dysfonction de proth\u00e8se peut \u00eatre suspect\u00e9e \u00e0 l'auscultation"], "answers": [false, true, true, false, true]}, {"title": "<p>Mr F 45 ans vient d&rsquo;&ecirc;tre op&eacute;r&eacute; d&rsquo;une dissection de l&rsquo;aorte thoracique secondaire &agrave; une bicuspidie cong&eacute;nitale. Une chirurgie de Bentall a &eacute;t&eacute; r&eacute;alis&eacute;e et une proth&egrave;se m&eacute;canique a &eacute;t&eacute; implant&eacute;e. Trois mois plus tard, il vous consulte dans votre cabinet de cardiologie car il se pose des questions sur le choix du chirurgien quant &agrave; la mise en place d&rsquo;une proth&egrave;se m&eacute;canique. Quel(s) est/sont le(s) avantage(s) et inconv&eacute;nient(s) d&rsquo;une telle proth&egrave;se ?</p>", "feedback": "<p dir=\"ltr\">Les avantages et inconv&eacute;nients des proth&egrave;ses cardiaques m&eacute;talliques sont :&nbsp;</p>\n<p><strong>&nbsp;</strong></p>\n<div dir=\"ltr\" align=\"left\">\n<table><colgroup><col><col></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\">Avantages&nbsp;</p>\n</td>\n<td>\n<p dir=\"ltr\">Inconv&eacute;nients&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dur&eacute;e prolong&eacute;e (&gt; 15 ans en l&rsquo;absence de complication)&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Patient jeune et en bonne sant&eacute;</p>\n</li>\n</ul>\n</td>\n<td>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anticoagulation &agrave; vie, avec risque de thrombose (si sous-dosage) ou risque de saignement (si surdosage).&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Endocardite infectieuse&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">D&eacute;sinsertion, h&eacute;molyse&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bruits de valve per&ccedil;us</p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p>&nbsp;</p>", "type": "qcm", "choices": ["Dur\u00e9e de vie prolong\u00e9e de la proth\u00e8se", "Anticoagulation n\u00e9cessaire seulement pendant les trois premiers mois.", "Valve silencieuse, particularit\u00e9 importante pour l\u2019endormissement, surtout chez les sujets jeunes.", "R\u00e9duction du risque d\u2019infection de valve du fait de sa composition m\u00e9tallique.", "Risque de d\u00e9sinsertion proth\u00e9tique"], "answers": [true, false, false, false, true]}, {"title": "<p>parmis les propositions suivantes, quels sont les 7 facteurs de risques li&eacute;es au patient de thrombose chez un porteur de proth&egrave;se valvulare ?&nbsp;</p>", "feedback": "<p>Les<strong> facteurs de risque de thrombose</strong> d'une proth&egrave;se valvulaire sont les suivants :&nbsp;</p>\n<ul>\n<li>positions mitrale, tricuspide ou pulmonaire ;</li>\n<li>ATCD thrombo-embolique ;</li>\n<li>fibrillation atriale ;</li>\n<li>r&eacute;trecissement mitrale associ&eacute; ;</li>\n<li>FEVG &lt; 35 %.</li>\n</ul>\n<p>Ils sont &agrave; conna&icirc;tre car la pr&eacute;sence d'un de ces facteurs de risques n&eacute;c&eacute;ssite une &eacute;l&eacute;vation de l'INR cible.</p>", "type": "qcm", "choices": ["position aortique", "position pulmonaire", "position tricuspide", "position mitrale", "FEVG \u00e0 45%", "FEVG \u00e0 30%", "patient \u00e2g\u00e9 de 80 ans", "ant\u00e9c\u00e9dents thromboembolique", "pr\u00e9sence d'un bloc trio-ventriculaire", "pr\u00e9sence d'un flotter atriale", "pr\u00e9sence d'une fibrillation atriale", "pr\u00e9sence d'un r\u00e9tr\u00e9cissement aortique", "pr\u00e9sence d'une st\u00e9nose mitrale"], "answers": [false, true, true, true, false, true, false, true, false, false, true, false, true]}, {"title": "<p>Quel(s) est (sont) le (les) avantage(s) d'une valve cardiaque m&eacute;canique ?</p>", "feedback": "<p>Les avantages sont :</p>\n<ul>\n<li>Longue dur&eacute;e de vie (th&eacute;oriquement toute la vie)</li>\n</ul>\n<p>Les inconv&eacute;nients sont :</p>\n<ul>\n<li>Ecoulement sanguin peu physiologique :</li>\n<ul>\n<li>H&eacute;molyse intravasculaire (mod&eacute;r&eacute;e)</li>\n<li>Thrombog&eacute;nicit&eacute; &eacute;lev&eacute;e : anticoagulation &agrave; vie par AVK</li>\n</ul>\n<li>Bruits de proth&egrave;se per&ccedil;us par le patient</li>\n</ul>", "type": "qcm", "choices": ["Pas d'anticoagulation n\u00e9cessaire", "Absence d'h\u00e9molyse", "Longue dur\u00e9e de vie", "D\u00e9g\u00e9n\u00e9rescence progressive", "Absence de perception des bruits de proth\u00e8se par le patient"], "answers": [false, false, true, false, false]}, {"title": "<p>Quels sont les inconv&eacute;nients d'une valve cardiaque m&eacute;canique ?</p>", "feedback": "<p>Les avantages sont :</p>\n<ul>\n<li>Longue dur&eacute;e de vie (th&eacute;oriquement toute la vie)</li>\n</ul>\n<p>Les inconv&eacute;nients sont :</p>\n<ul>\n<li>Ecoulement sanguin peu physiologique :</li>\n<ul>\n<li>H&eacute;molyse intravasculaire (mod&eacute;r&eacute;e)</li>\n<li>Thrombog&eacute;nicit&eacute; &eacute;lev&eacute;e : anticoagulation &agrave; vie par AVK</li>\n</ul>\n<li>Bruits de proth&egrave;se per&ccedil;us par le patient</li>\n</ul>", "type": "qcm", "choices": ["D\u00e9g\u00e9n\u00e9rescence progressive", "N\u00e9cessit\u00e9 d'une r\u00e9intervention \u00e0 distance", "Thombog\u00e9nicit\u00e9 \u00e9lev\u00e9e", "H\u00e9molyse intravasculaire", "Bruits de proth\u00e8se per\u00e7us par le patient"], "answers": [false, false, true, true, true]}, {"title": "<p>Quels sont les avantage d'une valve cardiaque de type bioproth&egrave;se ?</p>", "feedback": "<p>Les avantages sont :</p>\n<ul>\n<li>Bonnes performance h&eacute;modynamiques :&nbsp;</li>\n<ul>\n<li>Pas d'h&eacute;molyse intravasculaire</li>\n<li>Pas d'anticoagulation n&eacute;cessaire au long cours</li>\n</ul>\n</ul>\n<p>Les inconv&eacute;nients sont :</p>\n<ul>\n<li>D&eacute;g&eacute;n&eacute;rescence progressive et obligatoire&nbsp;=&gt; R&eacute;intervention n&eacute;c&eacute;ssaire entre 8 et 20 ans apr&egrave;s la chirurgie initiale</li>\n</ul>", "type": "qcm", "choices": ["Absence de d\u00e9g\u00e9n\u00e9rescence progressive", "H\u00e9molyse intravasculaire rare", "Absence d'anticoagulation au long cours n\u00e9cessaire", "Dur\u00e9e de vie tr\u00e8s longue", "Absence de risque de greffe septique sur le mat\u00e9riel"], "answers": [false, true, true, false, false]}, {"title": "<p>Quelles sont les complications possible chez un porteur de valve cardiaque m&eacute;canique ?</p>", "feedback": "<p>Les complications sont :</p>\n<ul>\n<li>Thrombose de valve</li>\n<li>Endocardite infectieuse sur proth&egrave;se</li>\n<li>D&eacute;sinsertion de proth&egrave;se</li>\n<li>H&eacute;molyse</li>\n<li>H&eacute;morragie sous AVK</li>\n<li>D&eacute;t&eacute;rioration structurelle des proth&egrave;ses m&eacute;caniques&nbsp;</li>\n</ul>", "type": "qcm", "choices": ["Thromboses de proth\u00e8se", "D\u00e9sinsertion de proth\u00e8se", "Endocardite infectieuse", "H\u00e9molyse", "D\u00e9t\u00e9rioration de proth\u00e8se"], "answers": [true, true, true, true, true]}, {"title": "<p>Quelles sont les complications possible chez un porteur de valve cardiaque &agrave; type de bioproth&egrave;se ?</p>", "feedback": "<p>Les complications sont :</p>\n<ul>\n<li>Endocardite infectieuse sur proth&egrave;se</li>\n<li>D&eacute;sinsertion de proth&egrave;se</li>\n<li>D&eacute;g&eacute;n&eacute;rescence de bioproth&egrave;se</li>\n<li>Elles n&eacute;cessitent 3 mois d'antiagr&eacute;gation (voir m&ecirc;me d'anticoagulation en fonction de leur position) apr&egrave;s leur pose</li>\n</ul>", "type": "qcm", "choices": ["D\u00e8s leur pose, elles ne n\u00e9cessitent pas d'antiagr\u00e9gation", "Endocardite infectieuse", "D\u00e9sinsertion de proth\u00e8se", "La durabilit\u00e9 d'une bioproth\u00e8se aortique est sup\u00e9rieure \u00e0 une bioproth\u00e8se mitrale", "D\u00e9g\u00e9n\u00e9rescence de proth\u00e8se"], "answers": [false, true, true, true, true]}, {"title": "<p>Quels sont les signes cliniques en faveur d'une thrombose occlusive de proth&egrave;se cardiaque ?</p>", "feedback": "<p>Les signes sont :</p>\n<ul>\n<li>Modification de l'auscultation :\n<ul>\n<li>Diminution voir abolition des bruits de fermeture et d'ouverture de la proth&egrave;se</li>\n<li>Apparition ou augmentation d'un souffle &eacute;jectionnel</li>\n<li>Un souffle de r&eacute;gurgitation est &eacute;galement possible</li>\n</ul>\n</li>\n<li>F&eacute;bricule&nbsp;</li>\n<li>Insuffisance cardiaque aigu&euml; r&eacute;fractaire</li>\n<li>Embolies art&eacute;rielles p&eacute;riph&eacute;riques multiples</li>\n<li>ACR</li>\n</ul>", "type": "qcm", "choices": ["Apparition d'un souffle \u00e9jectionnel", "Apparition d'un souffle de r\u00e9gurgitation", "F\u00e9bricule", "Insuffisance cardiaque rapidement corrig\u00e9e", "Embolie veineuse"], "answers": [true, true, true, false, false]}, {"title": "<p>A quels &acirc;ges pr&eacute;f&egrave;re-t-on poser une valve de type m&eacute;canique en position aortique ?</p>", "feedback": "<p>En position aortique la limite d'&acirc;ge est la suivante :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 60 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 60 - 65 ans</li>\n<li>Bioproth&egrave;se : &gt; 65 ans</li>\n</ul>\n<p>&nbsp;</p>\n<p>En position mitrale : (5 ans de plus qu'en position aortique) :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 65 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 65 - 70 ans</li>\n<li>Bioproth&egrave;se : &gt; 70 ans</li>\n</ul>", "type": "qcm", "choices": ["45 ans", "55 ans", "Entre 60 et 65 ans, l'usage d'une valve m\u00e9canique comme d'une bioproth\u00e8se se discute", "70 ans", "80 ans"], "answers": [true, true, true, false, false]}, {"title": "<p>A quel &acirc;ge pr&eacute;f&egrave;re-t-on poser une valve de type bioproth&egrave;se en position aortique ? (2 r&eacute;ponses attendues)&nbsp;</p>", "feedback": "<p>En position aortique la limite d'&acirc;ge est la suivante :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 60 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 60 - 65 ans</li>\n<li>Bioproth&egrave;se : &gt; 65 ans</li>\n</ul>\n<p>&nbsp;</p>\n<p>En position mitrale : (5 ans de plus qu'en position aortique) :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 65 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 65 - 70 ans</li>\n<li>Bioproth&egrave;se : &gt; 70 ans</li>\n</ul>", "type": "qcm", "choices": ["35 ans", "45 ans", "55 ans", "67 ans", "74 ans"], "answers": [false, false, false, true, true]}, {"title": "<p>A quel(s) age(s) pr&eacute;f&egrave;re-t-on poser une valve de type m&eacute;canique en position mitrale ?</p>", "feedback": "<p>En position mitrale la limite d'&acirc;ge est la suivante :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 65 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 65 - 70 ans</li>\n<li>Bioproth&egrave;se : &gt; 70 ans</li>\n</ul>\n<p>En position aortique : (5 ans de moins qu'en position mitrale) :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 60 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 60 - 65 ans</li>\n<li>Bioproth&egrave;se : &gt; 65 ans</li>\n</ul>", "type": "qcm", "choices": ["45 ans", "55 ans", "63 ans", "75 ans", "85 ans"], "answers": [true, true, true, false, false]}, {"title": "<p>A quel &acirc;ge pr&eacute;f&egrave;re-t-on poser une valve de type bioproth&egrave;se en position mitrale ?</p>", "feedback": "<p>En position mitrale la limite d'&acirc;ge est la suivante :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 65 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 65 - 70 ans</li>\n<li>Bioproth&egrave;se : &gt; 70 ans</li>\n</ul>\n<p>&nbsp;</p>\n<p>En position aortique : (5 ans de moins qu'en position mitrale) :</p>\n<ul>\n<li>Valve m&eacute;canique : &lt; 60 ans</li>\n<li>Valve m&eacute;canique ou bioproth&egrave;se : 60 - 65 ans</li>\n<li>Bioproth&egrave;se : &gt; 65 ans</li>\n</ul>", "type": "qcm", "choices": ["35 ans", "45 ans", "55 ans", "64 ans", "75 ans"], "answers": [false, false, false, false, true]}, {"title": "<p>Quel est la prise en charge d'une thrombose occlusive de proth&egrave;se valvulaire m&eacute;canique ?</p>", "feedback": "<p>La prise en charge repose :</p>\n<ul>\n<li>Hospitalisation en r&eacute;animation</li>\n<li>ETO pour diagnostic de certitude</li>\n<li>HNF d&egrave;s la suspicion diagnostic (&agrave; discuter, souvent non fait car un bloc urgent suppose un d&eacute;lai de 6-8h entre la fin de l'IVSE et l'incision)&nbsp;</li>\n<li>Traitement symptomatique en particulier de l'insuffisance cardiaque</li>\n<li>Radio-cin&eacute;ma de valve</li>\n<li>Traitement chirurgical de remplcament valvulaire en urgence&nbsp;</li>\n<li>Si traitement chirugical impossible =&gt; Fibrinolyse</li>\n</ul>\n<p>Pour les proth&egrave;ses biologiques, le traitement sera fait par AVK.</p>\n<p>Informations en Rang A dans le coll&egrave;ge de cardiologie.&nbsp;</p>", "type": "qcm", "choices": ["Fibrinolyse en 1ere intention", "Traitement anticoagulant fort dose par AVK", "ETO pour le diagnostic de certitude", "Radio-cin\u00e9ma de valve", "Prise en charge chirurgical \u00e0 distance"], "answers": [false, false, true, true, false]}, {"title": "<p>Quels sont les facteur thrombotique impactant sur le degr&eacute; d'anticoagulation n&eacute;cessaire chez un patient porteur d'une valve m&eacute;canique ?</p>", "feedback": "<p>Les facteurs sont :</p>\n<ul>\n<li>Risque thrombotique de la proth&egrave;se :<br>&ndash; faible : proth&egrave;ses m&eacute;caniques en position aortique : Medtronic Hall&reg; (valve &agrave; disque), ATS&reg;, Saint- Jude&reg;, On-X&reg;, Sorin Bicarbon&reg; et Carbomedics&reg; (valves &agrave; double ailette) ;<br>&ndash; moyen : valves &agrave; double ailette r&eacute;centes ou pour lesquelles les donn&eacute;es de suivi sont insuffisantes ;<br>&ndash; &eacute;lev&eacute; : Bj&ouml;rk-Shiley&reg; (monodisque), Starr&reg; (valve &agrave; bille).</li>\n<li>Facteurs de risque li&eacute;s au patient :<br>&ndash; proth&egrave;se en position mitrale ou tricuspide ;<br>&ndash; ant&eacute;c&eacute;dent thromboembolique ;<br>&ndash; FA ;<br>&ndash; st&eacute;nose mitrale associ&eacute;e ;<br>&ndash; FE &lt; 35 % ;<br>&ndash; hypercoagulabilit&eacute; en plus pour les recommandations am&eacute;ricaines</li>\n</ul>", "type": "qcm", "choices": ["Position mitrale de la valve", "Fibrillation auriculaire associ\u00e9e", "R\u00e9tr\u00e9cissement mitral associ\u00e9", "FeVG < 35%", "St\u00e9nose aortique associ\u00e9e"], "answers": [true, true, true, true, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique de Starr en position mitrale ?</p>", "feedback": "<p>Les objectifs sont les suivants :</p>\n<ul>\n<li>Faible thrombog&eacute;nicit&eacute; de la valve (double aillettes) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 2,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3</li>\n</ul>\n<li>Thrombog&eacute;nicit&eacute; interm&eacute;diaire de la valve :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3,5</li>\n</ul>\n<li>Forte thrombog&eacute;nicit&eacute; de la valve (Starr) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 4</li>\n</ul>\n</ul>\n<p>Conna&icirc;tre les valeurs cibles d'INR en fonction de la valve et du terrain: Rang A</p>", "type": "qcm", "choices": ["2", "2,5", "3", "3,5", "4"], "answers": [false, false, false, false, true]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique double aillettes en position aortique ?</p>", "feedback": "<p>Les objectifs sont les suivants :</p>\n<ul>\n<li>Faible thrombog&eacute;nicit&eacute; de la valve (double aillettes) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 2,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3</li>\n</ul>\n<li>Thrombog&eacute;nicit&eacute; interm&eacute;diaire de la valve :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3,5</li>\n</ul>\n<li>Forte thrombog&eacute;nicit&eacute; de la valve (Starr) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 4</li>\n</ul>\n</ul>", "type": "qcm", "choices": ["2", "2,5", "3", "3,5", "4"], "answers": [false, true, false, false, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique de Starr en position aortique ?</p>", "feedback": "<p>Les objectifs sont les suivants :</p>\n<ul>\n<li>Faible thrombog&eacute;nicit&eacute; de la valve (double aillettes) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 2,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3</li>\n</ul>\n<li>Thrombog&eacute;nicit&eacute; interm&eacute;diaire de la valve :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3,5</li>\n</ul>\n<li>Forte thrombog&eacute;nicit&eacute; de la valve (Starr) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 4</li>\n</ul>\n</ul>", "type": "qcm", "choices": ["2", "2,5", "3", "3,5", "4"], "answers": [false, false, false, true, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique double aillettes classique en position aortique associ&eacute;e &agrave; une fibrillation auriculaire ?</p>", "feedback": "<p>Les objectifs sont les suivants :</p>\n<ul>\n<li>Faible thrombog&eacute;nicit&eacute; de la valve (double aillettes + aortique ) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 2,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3</li>\n</ul>\n<li>Thrombog&eacute;nicit&eacute; interm&eacute;diaire de la valve :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3,5</li>\n</ul>\n<li>Forte thrombog&eacute;nicit&eacute; de la valve (Starr) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 4</li>\n</ul>\n</ul>\n<p>Ici faible thrombog&eacute;n&eacute;cit&eacute; + 1 FR -&gt; INR 3 (cf cardio surveillance de porteur de valve)</p>\n<p>NB : valve &agrave; double ailette classique / utilis&eacute;e en routine + position aortique = faible risque. Ce sont les valves &agrave; double ailette r&eacute;centes, sans recul pour affirmer qu'elles sont peu thrombotiques, qui sont &agrave; risque moyen.</p>\n<p>NB : petite incoh&eacute;rence avec chapitre FA qui dit INR entre 2 et 3 pour FA valvulaire simple. On choisit de se rapporter au chapitre surveillance de porteur de valve, beaucoup + pr&eacute;cis.&nbsp;</p>", "type": "qcm", "choices": ["2", "2,5", "3", "3,5", "4"], "answers": [false, false, true, false, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique double aillettes en position pulmonaire ?</p>", "feedback": "<p><em><sup>1</sup>Proth&egrave;se en position mitrale, tricuspide ou pulmonaire, ant&eacute;c&eacute;dent thromboembolique, fibrillation atriale, st&eacute;nose mitrale (quelle que soit la s&eacute;v&eacute;rit&eacute;), fraction d'&eacute;jection &lt; 35 </em></p>\n<p><em>Risque thrombotique des double aillettes = faible&nbsp;</em></p>\n<p><em>Donc 3</em></p><img src=data:image/png;base64,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>", "type": "qcm", "choices": ["2", "2,5", "3", "3,5", "4"], "answers": [false, false, true, false, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une bioproth&egrave;se en position mitrale depuis plusieurs ann&eacute;es?</p>", "feedback": "<p>Attention, PAS de traitement anticoagulant au long cours en cas de bioproth&egrave;se +++</p>", "type": "qcm", "choices": ["Pas de traitement anticoagulant", "2,5", "3", "3,5", "4"], "answers": [true, false, false, false, false]}, {"title": "<p>Quel est l'INR cible d'un patient ayant une valve m&eacute;canique Starr en position mitrale avec une FeVG = 25% ?</p>", "feedback": "<p>Les objectifs sont les suivants :</p>\n<ul>\n<li>Faible thrombog&eacute;nicit&eacute; de la valve (double aillettes) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 2,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3</li>\n</ul>\n<li>Thrombog&eacute;nicit&eacute; interm&eacute;diaire de la valve :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 3,5</li>\n</ul>\n<li>Forte thrombog&eacute;nicit&eacute; de la valve (Starr) :</li>\n<ul>\n<li>PAS d'autre facteur thrombotique =&gt; INR cible = 3,5</li>\n<li>&gt;= 1 autre facteur thrombotique =&gt; INR cible = 4</li>\n</ul>\n</ul>", "type": "qcm", "choices": ["3", "3,5", "4", "4,5", "5"], "answers": [false, false, true, false, false]}]